Onderneming InMed Pharmaceuticals Inc Deutsche Boerse AG
Aandelen
CA13764X1069
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- EUR | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
BayMedica
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 01-02-22 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 13-03-18 |
General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 12-05-22 |
Nicole Lemerond
BRD | Director/Board Member | 48 | 08-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 357 956 | 8 275 427 ( 99,01 %) | 0 | 99,01 % |
Bedrijfsgegevens
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |